Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Acquired Immunodeficiency Syndrome 1
- Aged 1
- Amikacin 1
- Animals 1
- Antibiotics, Antitubercular 1
- Antitubercular Agents 6
- Article 1
- Bacterial Proteins 2
- Capreomycin 1
- Cell Culture Techniques 1
- Ciprofloxacin 1
- Communicable Disease Control 1
- Communicable Diseases 1
- Culture Media 1
- Cyclonic Storms 1
- Diagnostic Tests, Routine 1
- Dispatch 1
- DNA Mutational Analysis 1
- Dog Diseases 1
- Dogs 1
- drug resistance 1
- Drug Resistance, Bacterial 2
- Ethambutol 1
- Female 2
- Full Report 1
- Genotype 2
- Geography 1
- Global Health 1
- HIV Infections 1
- Humans 7
- Ill-Housed Persons 1
- Isoniazid 2
- Kanamycin 1
- Laboratories 2
- Male 1
- Mechanisms of Resistance 1
- Microbial Sensitivity Tests 6
- Middle Aged 1
- molecular diagnostic tests 1
- Mutation 2
- Mycobacterium tuberculosis 4
- Mycobacterium Tuberculosis 1
- Mycobacterium Tuberculosis/drug effects 1
- Mycobacterium tuberculosis/drug effects 1
- Natural Disasters 1
- Ofloxacin 1
- Oxidoreductases 1
- Population Surveillance 1
- Probability 1
- Public Health Practice 1
- Pyrazinamide 1
- Racial Groups 1
- Research 1
- Research Article 2
- Retrospective Studies 1
- Reverse Transcriptase Polymerase Chain Reaction 1
- rifampicin resistance 1
- Rifampin 3
- Sentinel Surveillance 1
- Specimen Handling 1
- Sputum 2
- Time Factors 1
- Tuberculosis 4
- tuberculosis 1
- Tuberculosis, Multidrug-Resistant 5
- Tuberculosis, Pulmonary 1
- Zoonoses 1
Personal Author
Corporate Author
Place as Subject
- Africa 1
- Latvia 1
- Puerto Rico 1
- United States 1
Resource Type General
- Journal Article 9
- Letter 1
- Report 1
Resource Type Specific
- Letter 1
Select all docs (Max 200)
1 -
12 of 12 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Acquired Immunodeficiency Syndrome (1)
- Aged (1)
- Amikacin (1)
- Animals (1)
- Antibiotics, Antitubercular (1)
- Antitubercular Agents (6)
- Article (1)
- Bacterial Proteins (2)
- Capreomycin (1)
- Cell Culture Techniques (1)
- Ciprofloxacin (1)
- Communicable Disease Control (1)
- Communicable Diseases (1)
- Culture Media (1)
- Cyclonic Storms (1)
- Diagnostic Tests, Routine (1)
- Dispatch (1)
- DNA Mutational Analysis (1)
- Dog Diseases (1)
- Dogs (1)
- drug resistance (1)
- Drug Resistance, Bacterial (2)
- Ethambutol (1)
- Female (2)
- Full Report (1)
- Genotype (2)
- Geography (1)
- Global Health (1)
- HIV Infections (1)
- Humans (7)
- Ill-Housed Persons (1)
- Isoniazid (2)
- Kanamycin (1)
- Laboratories (2)
- Male (1)
- Mechanisms of Resistance (1)
- Microbial Sensitivity Tests (6)
- Middle Aged (1)
- molecular diagnostic tests (1)
- Mutation (2)
- Mycobacterium tuberculosis (4)
- Mycobacterium Tuberculosis (1)
- Mycobacterium Tuberculosis/drug effects (1)
- Mycobacterium tuberculosis/drug effects (1)
- Natural Disasters (1)
- Ofloxacin (1)
- Oxidoreductases (1)
- Population Surveillance (1)
- Probability (1)
- Public Health Practice (1)
- Pyrazinamide (1)
- Racial Groups (1)
- Research (1)
- Research Article (2)
- Retrospective Studies (1)
- Reverse Transcriptase Polymerase Chain Reaction (1)
- rifampicin resistance (1)
- Rifampin (3)
- Sentinel Surveillance (1)
- Specimen Handling (1)
- Sputum (2)
- Time Factors (1)
- Tuberculosis (4)
- tuberculosis (1)
- Tuberculosis, Multidrug-Resistant (5)
- Tuberculosis, Pulmonary (1)
- Zoonoses (1)
- :Yakrus, Mitchell A. ;Driscoll, JeffreyJun 08 2016 | Tuberc Res Treat. 2016; 2016.:Ethambutol (EMB) is used as a part of drug regimens for treatment of tuberculosis (TB). Susceptibility of Mycobacterium tuberculosis complex (MTBC) is...
- :Kurbatova, Ekaterina V. ;Cavanaugh, J. Sean2012 | Int J Tuberc Lung Dis. 16(3):355-357:Based on data from 14 Supranational Tuberculosis (TB) Reference Laboratories worldwide, the proportion of rifampicin (RMP) resistant isolates that wer...
- :Yakrus, Mitchell A. ;Metchock, BeverlyFeb 22 2015 | Tuberc Res Treat. 2015; 2015.:Crucial to interrupting the spread of tuberculosis (TB) is prompt implementation of effective treatment regimens. We evaluated satisfaction, comfort w...
- :Campbell, Patricia J. ;Morlock, Glenn P.May 2011 | Antimicrobial Agents and Chemotherapy. 2011; 55(5):2032-2041.:The emergence of multi- and extensively drug-resistant tuberculosis is a significant impediment to the control of this disease because treatment becom...
- :Mac Kenzie, William R. ;Heilig, Charles M.Apr 11 2011 | PLoS One. 6(4).:BackgroundTuberculosis Trials Consortium Study 28, was a double blind, randomized, placebo-controlled, phase 2 clinical trial examining smear positive...
- :Skenders, Girts ;Fry, Alicia M.Sep 2005 | Emerg Infect Dis. 11(9):1461-1463.:To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully introduced the rpoB gene mutation line probe assay into the national l...
- :Shah, N. Sarita ;Wright, AbigailMar 2007 | Emerg Infect Dis. 13(3):380-387.:Mycobacterium tuberculosis strains that are resistant to an increasing number of second-line drugs used to treat multidrug-resistant tuberculosis (MDR...
- :Kalokhe, Ameeta S. ;Shafiq, MajidMar 2012 | Emerg Infect Dis. 18(3):537-539.
- :Erwin, Paul C. ;Bemis, David A.Dec 2004 | Emerg Infect Dis. 10(12):2258-2260.
- :Stafford, Cortney ;Dalton, TracyMarch 2021 | Model Performance Evaluation Program (MPEP) Report:The purpose of this report is to present results of the U.S. Centers for Disease Control and Prevention (CDC) Model Performance Evaluation Program (MP...
- :Stafford, Cortney ;Metchock, BeverlySeptember 2017 | Model Performance Evaluation Program (MPEP) Report:The Model Performance Evaluation Program (MPEP) is an educational self-assessment tool in which five isolates of M. tuberculosis complex (MTBC) are se...
- :Concepción-Acevedo, Jeniffer ;Patel, AnitaMar 23 2018 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Hurricane Maria made landfall in Puerto Rico on September 20, 2017, causing major damage to infrastructure and severely limiting access to potable wat...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.